Transurethral polydimethylsiloxane injection: a valid minimally invasive option for the treatment of postradical hysterectomy urinary incontinence.
Urinary incontinence (UI) is a common complication after radical hysterectomy, ranging between 21% and 53%. Two cases of postradical hysterectomy UI treated with transurethral macroplastique injection are reported here. At 1-year follow-up, 1 patient showed no episodes of incontinence in voiding diary. The second patient showed a positive cough stress test only in standing position at 400 mL of bladder emptying. The frequency of UI according to a 3-day voiding diary was 3 episodes. Preoperative and postoperative subjective patient perception of UI symptom severity (visual analog scale) was 7-0 and 8-2 for cases 1 and 2, respectively. Bulking agents urethral injection could be a minimally invasive option to improve well-being of patients with cervical cancer after radical surgery.
Zullo
Marzio Angelo
MA
Departments of Obstetrics and Gynecology at Campus Bio Medico University of Rome, Rome, Italy.
Plotti
Francesco
F
Calcagno
Marco
M
Angioli
Roberto
R
Panici
Pierluigi Benedetti
PB
D001672:Biocompatible Materials / Q000627:therapeutic use*; D004129:Dimethylpolysiloxanes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects; D008875:Middle Aged; D019736:Prostheses and Implants; D014521:Urethra / Q000601:surgery*; D014549:Urinary Incontinence / Q000209:etiology / Q000601:surgery*
D001672:Biocompatible Materials; D004129:Dimethylpolysiloxanes; C013830:baysilon